Elanco Invests in the Future of Animal Health with $25 Million Ventures Platform
HEALTH & BEAUTY
Elanco Ventures.
Elanco Animal Health has announced the creation of Elanco Ventures, a dedicated corporate venture capital (CVC) platform backed by a $25 million multi‑year commitment to accelerate innovation across the animal health sector. The initiative represents a strategic investment in emerging technologies, early‑stage companies, and breakthrough solutions that support the evolving needs of pets, livestock producers, and the broader One Health community.
Launching in late 2026, Elanco Ventures will focus on identifying and supporting startups developing next‑generation therapeutics, diagnostics, and enabling technologies. The platform is designed to expand Elanco’s visibility into the rapidly evolving innovation landscape and strengthen its ability to meet rising global demand for protein and pet care.
A Strategic Investment in the Future of Animal Health
Elanco President and CEO Jeff Simmons emphasized that the animal health industry has never been more relevant. With innovation increasingly occurring outside traditional corporate boundaries, Elanco Ventures provides a structured way to partner with and invest in emerging companies shaping the future of care.
“From pets to protein, the animal health industry has never been more relevant than it is today,” Simmons said. “Innovation is happening outside of the boundaries of any single company. Elanco Ventures allows us to strategically leverage the startup landscape to expand our visibility into a range of emerging technologies that help us meet pet owners’ evolving expectation of care and the increasing global demand for protein.”
The fund will prioritize Pre‑Seed, Seed, and Series A companies, giving Elanco early access to transformative ideas and technologies.
Connecting Innovation Through the One Health Innovation District
While the platform’s primary focus is animal health, Elanco Ventures may also explore opportunities within the broader One Health landscape, the intersection of animal, human, and plant health.
The initiative will leverage the One Health Innovation District in Indianapolis, a first‑of‑its‑kind ecosystem anchored by Elanco and Purdue University. The district brings together researchers, life sciences organizations, diagnostics, commercialization partners, and entrepreneurs to accelerate discovery and delivery.
Tim Bettington, Executive Vice President of Elanco’s Center for Strategic Growth, noted that the platform embodies Elanco’s commitment to partnership and innovation. “By identifying promising startup technologies and collaborating with the One Health Innovation District, we are better positioned to fast‑track innovation that can redefine the future of animal health.”
Led by Experienced CVC Leadership
Elanco Ventures will be overseen by Eric Steager, an experienced corporate venture capital leader who will guide investment strategy, startup engagement, and portfolio development. The platform’s structure ensures that Elanco can support early‑stage companies while maintaining a clear focus on long‑term strategic value.
A New Era of Collaborative Innovation
With Elanco Ventures, the company is positioning itself at the forefront of animal health innovation, not only as a developer of products but as a catalyst for industry‑wide progress. By investing in emerging technologies and fostering collaboration across the One Health ecosystem, Elanco aims to accelerate solutions that improve animal well‑being, support global food systems, and enhance the lives of pet owners worldwide.
Related Stories
Lotti Media © 2025-2026
Lotti MEDIA is your go-to source for multi-industry insights, innovation, and more.
Stay in the Know
Join our mailing list today.
Powered by: Lotti Communications